{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:12:20Z","timestamp":1791220340598,"version":"4.1.0"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T00:00:00Z","timestamp":1369094400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0063563","type":"journal-article","created":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T17:23:25Z","timestamp":1369157005000},"page":"e63563","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":110,"title":["Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation"],"prefix":"10.1371","volume":"8","author":[{"given":"Lina","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Schwartzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lisac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Kleinschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Wilmot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bottomly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilsa","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"McWeeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshi","family":"Alumkal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,5,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"R Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ncponc0765","article-title":"Drug insight: role of the androgen receptor in the development and progression of prostate cancer","volume":"4","author":"ME Taplin","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(10)60172-9","article-title":"Antitumour Activity of MDV3100 in a Phase 1\u20132 Study of Castration-Resistant Prostate Cancer","volume":"375","author":"HI Scher","year":"2010","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1014618","article-title":"Abiraterone and increased survival in metastatic prostate cancer","volume":"364","author":"JS de Bono","year":"2011","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1200\/JCO.2010.33.7675","article-title":"Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone","volume":"30","author":"E Efstathiou","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Efstathiou E, Titus MA, Tsavachidou D, Hoang A, Karlou M, Wen S, <etal>et al<\/etal>.. (2011) MDV3100 effects on androgen receptor (AR) signaling and bone marrow testosterone concentration modulation: A preliminary report. J Clin Oncol 29: abstr 4501.","DOI":"10.1200\/jco.2011.29.15_suppl.4501"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1158\/0008-5472.CAN-08-3795","article-title":"A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth","volume":"69","author":"Z Guo","year":"2009","journal-title":"Cancer Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/0008-5472.CAN-08-2764","article-title":"Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer","volume":"69","author":"R Hu","year":"2009","journal-title":"Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1172\/JCI41824","article-title":"Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant","volume":"120","author":"S Sun","year":"2010","journal-title":"J Clin Invest"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ccr.2011.04.008","article-title":"Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer","volume":"19","author":"BS Carver","year":"2011","journal-title":"Cancer Cell"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ccr.2011.05.006","article-title":"Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth","volume":"19","author":"DJ Mulholland","year":"2011","journal-title":"Cancer Cell"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/humu.22046","article-title":"The androgen receptor gene mutations database: 2012 update","volume":"33","author":"B Gottlieb","year":"2012","journal-title":"Hum Mutat"},{"key":"ref13","first-page":"3550","article-title":"Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer","volume":"61","author":"MJ Linja","year":"2001","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ng0495-401","article-title":"In vivo amplification of the androgen receptor gene and progression of human prostate cancer","volume":"9","author":"T Visakorpi","year":"1995","journal-title":"Nat Genet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"7076","DOI":"10.1074\/jbc.M108255200","article-title":"Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways","volume":"277","author":"T Ueda","year":"2002","journal-title":"J Biol Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"13728","DOI":"10.1073\/pnas.1107898108","article-title":"Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer","volume":"108","author":"KH Chang","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cell.2009.04.056","article-title":"Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer","volume":"138","author":"Q Wang","year":"2009","journal-title":"Cell"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1535-6108(03)00197-1","article-title":"Myc-driven murine prostate cancer shares molecular features with human prostate tumors","volume":"4","author":"K Ellwood-Yen","year":"2003","journal-title":"Cancer Cell"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/pcan.2010.31","article-title":"Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence","volume":"13","author":"D Hawksworth","year":"2010","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref20","first-page":"524","article-title":"Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization","volume":"57","author":"RB Jenkins","year":"1997","journal-title":"Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1172\/JCI200319035","article-title":"Myc confers androgen-independent prostate cancer cell growth","volume":"112","author":"D Bernard","year":"2003","journal-title":"J Clin Invest"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"JE Delmore","year":"2011","journal-title":"Cell"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"16669","DOI":"10.1073\/pnas.1108190108","article-title":"Targeting MYC dependence in cancer by inhibiting BET bromodomains","volume":"108","author":"JA Mertz","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nm972","article-title":"Molecular determinants of resistance to antiandrogen therapy","volume":"10","author":"CD Chen","year":"2004","journal-title":"Nat Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ng1935","article-title":"Integrative molecular concept modeling of prostate cancer progression","volume":"39","author":"SA Tomlins","year":"2007","journal-title":"Nat Genet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.1168175","article-title":"Development of a second-generation antiandrogen for treatment of advanced prostate cancer","volume":"324","author":"C Tran","year":"2009","journal-title":"Science"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"9498","DOI":"10.1073\/pnas.150006697","article-title":"A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest","volume":"97","author":"GF Claassen","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1101\/gad.1067003","article-title":"Genomic targets of the human c-Myc protein","volume":"17","author":"PC Fernandez","year":"2003","journal-title":"Genes Dev"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1126\/science.1212728","article-title":"A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis","volume":"335","author":"JD Kessler","year":"2012","journal-title":"Science"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1182\/blood-2009-11-251074","article-title":"Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state","volume":"116","author":"J den Hollander","year":"2010","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.molcel.2009.08.020","article-title":"miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to \u201cseedless\u201d 3&apos;UTR microRNA recognition elements","volume":"35","author":"A Lal","year":"2009","journal-title":"Mol Cell"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1158\/0008-5472.CAN-08-0249","article-title":"Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth","volume":"68","author":"RB Montgomery","year":"2008","journal-title":"Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/pcan.2010.31","article-title":"Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence","volume":"13","author":"D Hawksworth","year":"2010","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Scher HI, Fizazi K, Saad F, Taplin ME, Sternberg CN, <etal>et al<\/etal>.. (2012) Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy. N Engl J Med.","DOI":"10.1056\/NEJMoa1207506"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1128\/MCB.00821-06","article-title":"Rapid loss of intestinal crypts upon conditional deletion of the Wnt\/Tcf-4 target gene c-Myc","volume":"26","author":"V Muncan","year":"2006","journal-title":"Mol Cell Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nature07260","article-title":"Modelling Myc inhibition as a cancer therapy","volume":"455","author":"L Soucek","year":"2008","journal-title":"Nature"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1158\/1078-0432.CCR-08-1726","article-title":"In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumors","volume":"15","author":"R Snoek","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1158\/1535-7163.MCT-11-0329","article-title":"Reduced expression of the androgen receptor by third generation of antisense shows antitumor activity in models of prostate cancer","volume":"10","author":"Y Zhang","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1016\/j.bmcl.2011.06.122","article-title":"Small-molecule androgen receptor downregulators as an approach to treatment of advanced prostate cancer","volume":"21","author":"RH Bradbury","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"ref40","unstructured":"Loddick S, Bradbury R, Broadbent N, Campbell H, Gaughan L, <etal>et al<\/etal>.. (2012) Preclinical profile of AZD3514: A small molecule-targeting androgen receptor function with a novel mechanism of action and the potential to treat castration-resistant prostate cancer. Cancer Res 72: abstr 3848."},{"key":"ref41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jsbmb.2005.04.029","article-title":"Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells","volume":"96","author":"P Haag","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"16663","DOI":"10.1073\/pnas.0908908106","article-title":"Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6","volume":"106","author":"A Gibbs","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10585-007-9116-4","article-title":"Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases","volume":"25","author":"C Morrissey","year":"2008","journal-title":"Clin Exp Metastasis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"10991","DOI":"10.1073\/pnas.0603678103","article-title":"A molecular correlate to the Gleason grading system for prostate adenocarcinoma","volume":"103","author":"L True","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/bioinformatics\/btq118","article-title":"Supervised normalization of microarrays","volume":"26","author":"BH Mecham","year":"2010","journal-title":"Bioinformatics"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1210\/jc.2010-1865","article-title":"Dihydrotestosterone administration does not increase intraprostatic androgen concentrations or alter prostate androgen action in healthy men: a randomized-controlled trial","volume":"96","author":"ST Page","year":"2011","journal-title":"J Clin Endocrinol Metab"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0063563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T20:54:32Z","timestamp":1563051272000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0063563"}},"subtitle":[],"editor":[{"given":"Natasha","family":"Kyprianou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,5,21]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0063563","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,21]]}}}